From Name:
From Email:
To Name:
To Email:

Optional Message:

Protein tyrosine phosphatase inhibitor reverses diabetes

from Nature Reviews Drug Discovery

The development of oral insulin-sensitizing agents to minimize the need for injectable insulin remains a major unmet need in the treatment of diabetes. Now, writing in Nature Chemical Biology, researchers report the identification of the first orally available small-molecule inhibitor of the low-molecular-weight phosphotyrosine protein phosphatase (LMPTP). more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063